Emrelis Disease Interactions
There are 4 disease interactions with Emrelis (telisotuzumab vedotin).
Telisotuzumab vedotin-tllv (applies to Emrelis) hepatic dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Telisotuzumab vedotin-tllv has not been studied in patients with moderate or severe hepatic dysfunction.
References (1)
- (2025) "Product Information. Emrelis (telisotuzumab vedotin)." AbbVie US LLC
Telisotuzumab vedotin-tllv (applies to Emrelis) interstitial lung disease or pneumonitis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Interstitial Pneumonitis
Interstitial lung disease or pneumonitis has occurred in patients treated with telisotuzumab vedotin-tllv. Patients should be monitored for new or worsening respiratory symptoms.
References (1)
- (2025) "Product Information. Emrelis (telisotuzumab vedotin)." AbbVie US LLC
Telisotuzumab vedotin-tllv (applies to Emrelis) peripheral neuropathy
Moderate Potential Hazard, Moderate plausibility.
Peripheral neuropathy, including peripheral sensory neuropathy and peripheral motor neuropathy has occurred in patients treated with telisotuzumab vedotin-tllv. Patients should be monitored for signs and symptoms of new or worsening peripheral neuropathy such as hypoesthesia, hyperesthesia, paresthesia, a burning sensation, neuropathic pain, or muscle weakness.
References (1)
- (2025) "Product Information. Emrelis (telisotuzumab vedotin)." AbbVie US LLC
Telisotuzumab vedotin-tllv (applies to Emrelis) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Telisotuzumab vedotin-tllv has not been studied in patients with severe renal dysfunction, and end-stage renal disease with or without dialysis.
References (1)
- (2025) "Product Information. Emrelis (telisotuzumab vedotin)." AbbVie US LLC
Switch to consumer interaction data
Emrelis drug interactions
There are 382 drug interactions with Emrelis (telisotuzumab vedotin).
Report options
More about Emrelis (telisotuzumab vedotin)
- Emrelis consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
